Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,296 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Interim 2023/2024 Season Influenza Vaccine Effectiveness in Primary and Secondary Care in the United Kingdom.
Whitaker H, Findlay B, Zitha J, Goudie R, Hassell K, Evans J, Kalapotharakou P, Agrawal U, Kele B, Hamilton M, Moore C, Byford R, Stowe J, Robertson C, Couzens A, Jamie G, Hoschler K, Pheasant K, Button E, Quinot C, Jones T, Anand S, Watson C, Andrews N, de Lusignan S, Zambon M, Williams C, Cottrell S, Marsh K, McMenamin J, Lopez Bernal J. Whitaker H, et al. Among authors: andrews n. Influenza Other Respir Viruses. 2024 May;18(5):e13284. doi: 10.1111/irv.13284. Influenza Other Respir Viruses. 2024. PMID: 38773753 Free PMC article.
Idiopathic thrombocytopenic purpura and MMR vaccine.
Miller E, Waight P, Farrington CP, Andrews N, Stowe J, Taylor B. Miller E, et al. Among authors: andrews n. Arch Dis Child. 2001 Mar;84(3):227-9. doi: 10.1136/adc.84.3.227. Arch Dis Child. 2001. PMID: 11207170 Free PMC article.
Safety and immunogenicity of AS03B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label, randomised, parallel group, multicentre study.
Waddington CS, Walker WT, Oeser C, Reiner A, John T, Wilkins S, Casey M, Eccleston PE, Allen RJ, Okike I, Ladhani S, Sheasby E, Hoschler K, Andrews N, Waight P, Collinson AC, Heath PT, Finn A, Faust SN, Snape MD, Miller E, Pollard AJ. Waddington CS, et al. Among authors: andrews n. BMJ. 2010 May 27;340:c2649. doi: 10.1136/bmj.c2649. BMJ. 2010. PMID: 20508026 Free PMC article. Clinical Trial.
Open-label, randomised, parallel-group, multicentre study to evaluate the safety, tolerability and immunogenicity of an AS03(B)/oil-in-water emulsion-adjuvanted (AS03(B)) split-virion versus non-adjuvanted whole-virion H1N1 influenza vaccine in UK children 6 months to 12 years of age.
Waddington C, Andrews N, Hoschler K, Walker W, Oeser C, Reiner A, John T, Wilkins S, Casey M, Eccleston P, Allen R, Okike I, Ladhani S, Sheasby E, Waight P, Collinson A, Heath P, Finn A, Faust S, Snape M, Miller E, Pollard A. Waddington C, et al. Among authors: andrews n. Health Technol Assess. 2010 Oct;14(46):1-130. doi: 10.3310/hta14460-01. Health Technol Assess. 2010. PMID: 20923610 Free article. Clinical Trial.
1,296 results